CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Triptorelin pamoate

Last Updated: February 27, 2006
Result type: Reports
Project Number: SR0051-000
Product Line: Reimbursement Review

Generic Name: Triptorelin pamoate

Brand Name: Trelstar

Manufacturer: Watson Laboratories Inc.

Therapeutic Area: Cancer, prostate

Indications: Cancer, prostate

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 20, 2006

Recommendation Type: List in a similar manner to other drugs in class